Navigation Links
AtheroNova Signs Agreement for Development of Clinical Trial Supplies
Date:4/25/2012

and a-80 bed Phase 1 Unit in Changchun, Jiling Province China.  Frontage has an AALAC certified preclinical animal facility in Pennsylvania, where it also maintains bioanalytical and CMC facilities. In Shanghai and Beijing, China, the company also operates bioanalytical and CMC facilities.  The Frontage CMC Division provide services in the areas of custom API synthesis and GMP manufacturing, analytical testing, formulation development and manufacturing of clinical trial materials including Sterile (Injection and Ophthalmic), Oral Solid (IR and CR), Topical, and High Potent products.  As a rapidly expanding CRO with ten years of success providing high-quality GXP services, Frontage has established an international standard in pharmaceutical product research, development, quality and management systems.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the Company's product shipments, suitability of the compound for its intended use, mechanisms of action, clinical trials and supply chain as well as the development of applications for AtheroNova's technology. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as significant fluctuations in expenses associated with clinical trials, failure to secure additional financing, the inability to complete regulatory filings with the Food and Drug Administration, the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other infor
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Agrees With AtheroNovas Clinical Development Plan as Proposed
2. AtheroNova Completes Successful Pre-IND Meeting with FDA on AHRO-001
3. HealthyWomen Asks: Do You Know the Signs and Symptoms of von Willebrand Disease (VWD)?
4. Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona
5. Fortis Healthcare Signs Agreement Giving Indias Fastest-Growing Hospital Chain Access to Masimos State-of-the-Art Noninvasive Patient Monitoring Solutions
6. Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora™ Oral Calcitonin Product With QS Pharma
7. Altitude Organic New Dispensary Counter-Space Acquisition Program - Zazzz™ - Signs Premier Location
8. Universal Capital Management Signs Letter of Intent to Purchase ProShield™ Assets
9. QRxPharma Signs License and Option Agreement with Actavis
10. Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement for China
11. The Centers for Disease Control & Prevention Signs Vaccine Warehouse and Distribution Contract with Sentry BioPharma Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapeutics primarily in the ... medical needs, today reported its financial results for ... 2014, and provided a business update. ... "The past year has seen a steady growth ...
(Date:3/30/2015)...  Confirming its investment in the area of ... of Darmstadt,s announcement on the launch of the ... German government. Directed at developing ... as way to protect and prevent the brain ... anti-inflammatory and antioxidant activities of olive polyphenols, especially ...
(Date:3/29/2015)... 2015  Three-month paliperidone palmitate, an investigational atypical ... placebo in patients with schizophrenia, according to a ... in the Journal of the American ... Results of the study served as the basis ... for three-month paliperidone palmitate injection to treat schizophrenia ...
Breaking Medicine Technology:RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 2RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 3RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 4RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 5RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 6RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 7RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 8RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 9RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 10CreAgri Reaffirms Its Commitment to Neuroprotection and Alzheimer's Prevention in Light of German Research Project 2CreAgri Reaffirms Its Commitment to Neuroprotection and Alzheimer's Prevention in Light of German Research Project 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12
... 2011 Reportlinker.com announces that a new market research ... The 2011 US Coagulation Market ... comprehensive analysis of the US coagulation market, including: ... practice, as well as key economic, regulatory, demographic, social ...
... Mobile Dog Heart Health Tour is heading to Jacksonville for ... Johns Town Center from 11 a.m. to 3 p.m. on ... screenings in a soundproof medical unit, as well as educate ... http://photos.prnewswire.com/prnh/20110127/CG37742 ) Since early 2009, veterinarians on the ...
Cached Medicine Technology:Reportlinker Adds The 2011 US Coagulation Market 2Free Dog Heart Checks in Jacksonville 2Free Dog Heart Checks in Jacksonville 3
(Date:3/30/2015)... Mo. (PRWEB) March 30, 2015 ... a mobile library of medications used in behavioral ... for iPhone, iPad and Android—is a convenient, electronic ... annually since 1999. The useful resource provides up-to-date ... purpose, dosage and frequency, side effects, emergency conditions, ...
(Date:3/30/2015)... IL (PRWEB) March 30, 2015 ... marketing company for mental health professionals, announced today ... relationship allows TherapySites to extend their online marketing ... promotional offers. , "As we continue to see ... to leverage the Internet effectively in order to ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 National Nutrition ... stock of their eating habits and commit to nutritious decisions ... the future. According to a recent study from the U.S. ... comes from snack food. Making healthy snack choices needs to ... a busy society constantly on the go. , Each day, ...
(Date:3/29/2015)... March 29, 2015 Pro Ace Care ... company will now provide qualified HVAC technicians that will ... heat pumps and related systems throughout Vancouver, North Vancouver, ... and air conditioners, heat pumps require regular maintenance from ... such as BC Hydro strongly suggest you have it ...
(Date:3/29/2015)... Lake Orion, Clarkston, Metamora, MI. (PRWEB) March 29, 2015 ... with Beaumont Hospital, offers comprehensive menopause treatment. Secondary ... in that area a closer hospital option. They ... Oakland and McLaren Oakland. , Menopause is ... age. The term "menopause" can describe any of the ...
Breaking Medicine News(10 mins):Health News:Popular Publication on Behavioral Health Medications Now An App 2Health News:TherapySites (Websites for Therapists) Partners with BehaveNet 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 3Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2
... Families And Increase Landlord ... Accountability, ... The Sherwin-Williams Company are pleased to announce "NOT,IN OUR HOUSE," an ... poor maintenance and neglect and to encourage property,owners and landlords to ...
... Md., Sept. 10 Maxim Health Systems today,announced it ... 29, 2007. Maxim will provide flu shots nationwide through ... site, http://www.FindAFluShot.com, helps users find a convenient location ... code on the site to,obtain times and locations for ...
... Conflict is an issue that children,often face on a ... on,how to communicate effectively to handle a confrontation or ... can be harmful,to children, whether mentally or physically, because ... management issues. It is important to establish and ...
... lesser known,antibiotic-resistant bacteria is a growing danger to ... the potentially deadly staph,infection known as Community Acquired-Methicillin-Resistant ... Texas was one of the first regions of ... a hot bed for the infection. "We,ve ...
... Freedom to Breathe Act, MINNEAPOLIS, Sept. 10 ... campaign designed to educate and excite Minnesotans about ... that goes into effect,on October 1. The new ... restaurants and private clubs. Called Fresh Air, the,multimedia ...
... Their Contributions ... to the Advancement of Science, PHILADELPHIA and ... (NYSE: TOC ; TSX: TOC) and,leading provider of information ... 2007 Thomson Scientific Laureates,-- researchers likely to be in contention ...
Cached Medicine News:Health News:National Council of Negro Women (NCNW) Partners With Sherwin-Williams to Target Lead Risks in Neglected Housing 2Health News:Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide 2Health News:Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide 3Health News:Tips for Parents: Teaching Children to Resolve Conflicts 2Health News:South Texas Doctors Report More Severe Cases of Community Staph 'Super Bug' Hospitalizing Children 2Health News:Fresh Air Campaign to Showcase Minnesotans' Love of Smoke-Free Air 2Health News:Thomson Scientific Predicts Nobel Laureates 2Health News:Thomson Scientific Predicts Nobel Laureates 3Health News:Thomson Scientific Predicts Nobel Laureates 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: